Since there are contradictory data regarding the association of antiplatelet pretreatment (AP) with safety and efficacy outcomes of intravenous thrombolysis (IVT) for acute ischemic stroke (AIS), we conducted a systematic review and meta-analysis of available randomized-controlled clinical trials (RCTs) to investigate the association of AP with outcomes of AIS patients treated with intravenous alteplase. The outcome events of interest included symptomatic intracranial hemorrhage (sICH), fatal ICH, complete recanalization (CR), 3-month favorable functional outcome (FFO, mRS score 0–1), 3-month functional independence (FI, mRS score 0–2), and mortality. The corresponding odds ratios (ORs) were calculated for all the outcome events using rando...
PubMed ID: 26173726Background and Purpose - A recent meta-analysis investigating the association bet...
SummaryBackgroundAlteplase is effective for treatment of acute ischaemic stroke but debate continues...
Background: Debate exists as to whether statin pretreatment confers an increased risk of 90-day mort...
Since there are contradictory data regarding the association of antiplatelet pretreatment (AP) with ...
Background: There is some uncertainty whether prior use of antiplatelet (AP) drugs increases the ris...
Background and Purpose-Antiplatelets (APs) may increase the risk of symptomatic intracerebral hemorr...
Objective: Conflicting data exist regarding the safety and efficacy of IV thrombolysis (IVT) in acut...
Background: One quarter to one third of patients eligible for systemic thrombolysis are on antiplate...
Background: Antiplatelet therapy may increase the risk of symptomatic intracranial hemorrhage after ...
Background and Purpose : The influence of chronic treatment by antiplatelet drug (APD) at stroke ons...
Background Antiplatelet therapy may increase the risk of symptomatic intracranial hemorrhage after e...
Background: Debate exists as to whether statin pretreatment confers an increased risk of 90- day mor...
BACKGROUND: Debate exists as to whether statin pretreatment confers an increased risk of 90-day mort...
Background: One quarter to one third of patients eligible for systemic thrombolysis are on antipla...
Endovascular therapy (EVT) represents the gold standard treatment in patients affected by acute isch...
PubMed ID: 26173726Background and Purpose - A recent meta-analysis investigating the association bet...
SummaryBackgroundAlteplase is effective for treatment of acute ischaemic stroke but debate continues...
Background: Debate exists as to whether statin pretreatment confers an increased risk of 90-day mort...
Since there are contradictory data regarding the association of antiplatelet pretreatment (AP) with ...
Background: There is some uncertainty whether prior use of antiplatelet (AP) drugs increases the ris...
Background and Purpose-Antiplatelets (APs) may increase the risk of symptomatic intracerebral hemorr...
Objective: Conflicting data exist regarding the safety and efficacy of IV thrombolysis (IVT) in acut...
Background: One quarter to one third of patients eligible for systemic thrombolysis are on antiplate...
Background: Antiplatelet therapy may increase the risk of symptomatic intracranial hemorrhage after ...
Background and Purpose : The influence of chronic treatment by antiplatelet drug (APD) at stroke ons...
Background Antiplatelet therapy may increase the risk of symptomatic intracranial hemorrhage after e...
Background: Debate exists as to whether statin pretreatment confers an increased risk of 90- day mor...
BACKGROUND: Debate exists as to whether statin pretreatment confers an increased risk of 90-day mort...
Background: One quarter to one third of patients eligible for systemic thrombolysis are on antipla...
Endovascular therapy (EVT) represents the gold standard treatment in patients affected by acute isch...
PubMed ID: 26173726Background and Purpose - A recent meta-analysis investigating the association bet...
SummaryBackgroundAlteplase is effective for treatment of acute ischaemic stroke but debate continues...
Background: Debate exists as to whether statin pretreatment confers an increased risk of 90-day mort...